Beyond Joints: The Importance of Animal Models in Exploring Rheumatoid Arthritis Comorbidities

Miguel Marco-Bonilla¹María Fresnadillo¹Macarena de la Riva-Bueno¹Gabriel HERRERO-BEAUMONT¹Miguel Angel González-Gay^1,2*Raquel Largo¹Aranzazu Mediero¹

• ¹Joint and Bone Research Unit, IIS Fundación Jiménez Díaz UAM, Madrid, Spain
• ²Medicine and Psychiatry Department, University of Cantabria, Santander, Spain

Joint inflammation is the most prominent feature of rheumatoid arthritis (RA), but this disease can affect practically any organ of the body. The association between RA and comorbidities is multifaceted, involving traditional risk factors, chronic inflammation, and the effects of medications. A large number of animal models have been developed for the study of RA. All of them developed histopathological changes like the human disease and often experienced other comorbidities. The choice of one model or another depends on several factors. It is important to bear in mind, for example, the study of pathophysiological mechanisms, the progression and the activated autoimmunity among others. It is also necessary to know what comorbidities are described in each model, as the selection may depend on the possibility to replicate these comorbidities. In this review we will focus on the study of cardiovascular, musculoskeletal and hepatic comorbidities in the four most used induced RA models: Collagen-Induced Arthritis (CIA), Adjuvant-Induced Arthritis (AIA), Pristane-Induced Arthritis (PIA) and serum transfer K/BxN. In this manuscript we offer guidance on how these models replicate RA key comorbidities and how to choose the most suitable RA model.